NYSE:ELVHealthcare
Is It Time To Reassess Elevance Health (ELV) After Its Recent Share Price Swing
For investors considering whether Elevance Health at around US$374.71 represents an opportunity or already reflects its quality, this article focuses on what the numbers indicate about value.
The stock has seen mixed returns, with a 23.8% gain over the last 30 days, a 5.8% return year to date, and a 1-year return of an 8.3% decline.
Recent coverage of Elevance Health has focused on its position as a major US health insurer and how ongoing shifts in healthcare spending and policy are...